{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,30]],"date-time":"2025-05-30T04:05:06Z","timestamp":1748577906870,"version":"3.41.0"},"reference-count":12,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,5,29]],"date-time":"2025-05-29T00:00:00Z","timestamp":1748476800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,5,29]],"date-time":"2025-05-29T00:00:00Z","timestamp":1748476800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100014717","name":"National Outstanding Youth Science Fund Project of National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82101515"],"award-info":[{"award-number":["82101515"]}],"id":[{"id":"10.13039\/100014717","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Acta Epileptologica"],"published-print":{"date-parts":[[2025,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Unverricht-Lundborg disease (ULD) is a rare autosomal recessive neurodegenerative disorder, often caused by biallelic promoter expansions of <jats:italic>CSTB<\/jats:italic> gene or, more rarely by point\/indel variants. The best-known area for ULD are the shores of the Baltic and Mediterranean Sea and few cases have been recorded from Asia.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Case presentation<\/jats:title>\n            <jats:p>In this report, we present the first case of a Chinese patient with ULD. The patient was a 21-year-old female with normal cognitive function. She developed nocturnal bilateral tonic\u2013clonic seizures (BTCS) at age 8, with subsequent onset of myoclonic jerks along with ataxia at age 12. Myoclonic jerks were triggered by flashing lights and during menstrual periods. EEG recording showed multifocal spikes and sharp-waves, predominantly in bilateral occipital regions. Genetic testing revealed heterozygous compound variants for a novel indel variant (c.116 -\u2009117 delAG) and the repeat expansion of <jats:italic>CSTB<\/jats:italic> gene. The refractory BTCS and myoclonic jerks showed remarkable response to low-dose (2 mg\/day) perampanel treatment. After 24 months of follow-up, the patient remained seizure-free, but her myoclonic jerks recurred, which could be reduced by increasing the dosage of perampanel.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>To the best of our knowledge, this is the first report of ULD in the large Chinese population. By comparison with homozygous promoter expansions, we found an earlier age of first symptom onset and more refractory BTCS of ULD patients with compound or homozygous point\/indel variants.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/s42494-025-00216-4","type":"journal-article","created":{"date-parts":[[2025,5,29]],"date-time":"2025-05-29T09:04:03Z","timestamp":1748509443000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["A novel c.116 -\u2009117 del variant in Unverricht-Lundborg disease: first ULD report in large Chinese population and review of the pathogenetic variants in CSTB gene"],"prefix":"10.1186","volume":"7","author":[{"given":"Pu","family":"Miao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yao","family":"Ding","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhidong","family":"Cen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yulan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Luo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Baorong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhiying","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meiping","family":"Ding","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,5,29]]},"reference":[{"key":"216_CR1","doi-asserted-by":"publisher","DOI":"10.1016\/j.yebeh.2020.107439","volume":"112","author":"M Bosak","year":"2020","unstructured":"Bosak M, Su\u0142ek A, \u0141ukasik M, \u017bak A, S\u0142owik A, Lasek-Bal A. Genetic testing and the phenotype of Polish patients with Unverricht-Lundborg disease (EPM1) - A cohort study. Epilepsy Behav. 2020;112:107439.","journal-title":"Epilepsy Behav"},{"issue":"12","key":"216_CR2","doi-asserted-by":"publisher","first-page":"2120","DOI":"10.1111\/j.1528-1167.2012.03718.x","volume":"53","author":"L Canafoglia","year":"2012","unstructured":"Canafoglia L, Gennaro E, Capovilla G, Gobbi G, Boni A, Beccaria F, et al. Electroclinical presentation and genotype-phenotype relationships in patients with Unverricht-Lundborg disease carrying compound heterozygous CSTB point and indel mutations. Epilepsia. 2012;53(12):2120\u20137.","journal-title":"Epilepsia"},{"issue":"6","key":"216_CR3","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1038\/ejhg.2017.39","volume":"25","author":"A O'Brien","year":"2017","unstructured":"O\u2019Brien A, Marshall CR, Blaser S, Ray PN, Yoon G. Severe neurodegeneration, progressive cerebral volume loss and diffuse hypomyelination associated with a homozygous frameshift mutation in CSTB. Eur J Hum Genet. 2017;25(6):775\u20138.","journal-title":"Eur J Hum Genet"},{"key":"216_CR4","doi-asserted-by":"crossref","unstructured":"Lucchino V, Scaramuzzino L, Scalise S, Lo Conte M, Zannino C, Benedetto GL, et al. Insights into the Genetic Profile of Two Siblings Affected by Unverricht-Lundborg Disease Using Patient-Derived hiPSCs. Cells. 2022;11(21):3491.","DOI":"10.3390\/cells11213491"},{"issue":"23","key":"216_CR5","doi-asserted-by":"publisher","first-page":"e3117","DOI":"10.1212\/WNL.0000000000010911","volume":"95","author":"JOT Sipil\u00e4","year":"2020","unstructured":"Sipil\u00e4 JOT, Hypp\u00f6nen J, Kyt\u00f6 V, K\u00e4lvi\u00e4inen R. Unverricht-Lundborg disease (EPM1) in Finland: A nationwide population-based study. Neurology. 2020;95(23):e3117\u201323.","journal-title":"Neurology"},{"issue":"5256","key":"216_CR6","doi-asserted-by":"publisher","first-page":"1731","DOI":"10.1126\/science.271.5256.1731","volume":"271","author":"LA Pennacchio","year":"1996","unstructured":"Hypp\u00f6nen J, \u00c4iki\u00e4 M, Joensuu T, Julkunen P, Danner N, Koskenkorva P, et al. Refining the phenotype of Unverricht-Lundborg disease (EPM1): a population-wide Finnish study. Neurology. 2015;84(15):1529\u201336.","journal-title":"Science"},{"key":"216_CR7","doi-asserted-by":"crossref","unstructured":"Koskenkorva P, Hypp\u00f6nen J, Aiki\u00e4 M, Mervaala E, Kiviranta T, Eriksson K, et al. Severer phenotype in Unverricht-Lundborg disease (EPM1) patients compound heterozygous for the dodecamer repeat expansion and the c.202C>T mutation in the CSTB gene. Neurodegener Dis. 2011;8(6):515\u201322.","DOI":"10.1159\/000323470"},{"key":"216_CR8","unstructured":"Lalioti MD, Mirotsou M, Buresi C, Peitsch MC, Rossier C, Ouazzani R, et al. Identifcation of mutations in cystatin B, the gene responsible for the Unverricht-Lundborg type of progressive myoclonus epilepsy (EPM1). Am J Hum Genet. 1997;60(2):342\u201351."},{"issue":"6","key":"216_CR9","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1159\/000323470","volume":"8","author":"P Koskenkorva","year":"2011","unstructured":"Pinto E, Freitas J, Duarte AJ, Ribeiro I, Ribeiro D, Lima JL, et al. Unverricht-Lundborg disease: homozygosity for a new splicing mutation in the cystatin B gene. Epilepsy Res. 2012;99(1-2):187\u201390.","journal-title":"Neurodegener Dis"},{"key":"216_CR10","doi-asserted-by":"crossref","unstructured":"Matthews AM, Blydt-Hansen I, Al-Jabri B, Andersen J, Tarailo-Graovac M, Price M, et al. Atypical cerebral palsy: genomics analysis enables precision medicine. Genet Med. 2019;21(7):1621\u20138.","DOI":"10.1038\/s41436-018-0376-y"},{"key":"216_CR11","doi-asserted-by":"crossref","unstructured":"Kagitani-Shimono K, Imai K, Okamoto N, Ono J, Okada S. Unverricht-Lundborg disease with cystatin B gene abnormalities. Pediatr Neurol. 2002;26(1):55\u201360.","DOI":"10.1016\/S0887-8994(01)00336-8"},{"key":"216_CR12","doi-asserted-by":"crossref","unstructured":"Assenza G, Benvenga A, Gennaro E, Tombini M, Campana C, Assenza F, et al. A novel c132-134del mutation in Unverricht-Lundborg disease and the review of literature of heterozygous compound patients. Epilepsia. 2017;58(2):e31\u2013e35.","DOI":"10.1111\/epi.13626"}],"container-title":["Acta Epileptologica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s42494-025-00216-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s42494-025-00216-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s42494-025-00216-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,29]],"date-time":"2025-05-29T09:04:06Z","timestamp":1748509446000},"score":1,"resource":{"primary":{"URL":"https:\/\/aepi.biomedcentral.com\/articles\/10.1186\/s42494-025-00216-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,29]]},"references-count":12,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["216"],"URL":"https:\/\/doi.org\/10.1186\/s42494-025-00216-4","relation":{},"ISSN":["2096-9384","2524-4434"],"issn-type":[{"value":"2096-9384","type":"print"},{"value":"2524-4434","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,29]]},"assertion":[{"value":"2 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethical approval for this study was granted by Second Affiliated Hospital, School of Medicine, Zhejiang University. Informed consent was obtained from participant in written form prior to their involvement in the research (2013\u20130321).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"None.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"32"}}